{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:46:22Z","timestamp":1773773182637,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.contraception.2005.09.011","type":"journal-article","created":{"date-parts":[[2005,11,17]],"date-time":"2005-11-17T12:16:37Z","timestamp":1132229797000},"page":"348-351","source":"Crossref","is-referenced-by-count":20,"title":["Effects of two different oral contraceptives on homocysteine metabolism in women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"73","author":[{"given":"Angelo","family":"Cagnacci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Tirelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonietta","family":"Renzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annibale","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2005.09.011_bib1","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.fertnstert.2005.01.085","article-title":"Diagnostic criteria for polycystic ovary syndrome: a reappraisal","volume":"83","author":"Azziz","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2005.09.011_bib2","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0015-0282(02)03111-4","article-title":"Insulin resistance, polycystic ovary syndrome and type 2 diabetes mellitus","volume":"77","author":"Ovalle","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2005.09.011_bib3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1055\/s-2002-26735","article-title":"Polycystic ovary syndrome and metabolic syndrome","volume":"127","author":"Auerhammer","year":"2002","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.contraception.2005.09.011_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000058367","article-title":"The plasma homocysteine levels are increased in polycystic ovary syndrome","volume":"53","author":"Loverro","year":"2002","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.contraception.2005.09.011_bib5","first-page":"197","article-title":"Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects","volume":"139","author":"Giltay","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.contraception.2005.09.011_bib6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0967-2109(97)00062-8","article-title":"Homocysteinemia as a risk factor for atherosclerosis: a review","volume":"5","author":"Nehler","year":"1997","journal-title":"Cardiovasc Surg"},{"key":"10.1016\/j.contraception.2005.09.011_bib7","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1172\/JCI116187","article-title":"Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen","volume":"91","author":"Stamler","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.contraception.2005.09.011_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/s-2000-8469","article-title":"Homocysteine coagulation, platelet function and thrombosis","volume":"26","author":"Coppola","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.contraception.2005.09.011_bib9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1055\/s-2000-8472","article-title":"Hyperhomocysteinemia vascular pathology and endothelial dysfunction","volume":"26","author":"Van Guldener","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.contraception.2005.09.011_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0002-8223(98)00014-5","article-title":"Oral contraceptives did not affect biochemical folate indexes and homocysteine concentrations in adolescent females","volume":"98","author":"Green","year":"1998","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.contraception.2005.09.011_bib11","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1053\/meta.2002.34038","article-title":"Effects of two oral contraceptives on plasma levels of nitric oxide, homocysteine and lipid metabolism","volume":"51","author":"Merki-Feld","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.contraception.2005.09.011_bib12","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0015-0282(16)57966-7","article-title":"Evidence that an altered prolactin release is consequent to abnormal ovarian activity in polycystic ovary syndrome","volume":"64","author":"Paoletti","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2005.09.011_bib13","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jcem-71-6-1508","article-title":"Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects","volume":"71","author":"Welch","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2005.09.011_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1530\/eje.0.1450281","article-title":"Insulin sensitivity in women: a comparison among values derived from intravenous glucose tolerance test with different sampling frequency, oral glucose tolerance test or fasting","volume":"145","author":"Cagnacci","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.contraception.2005.09.011_bib15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/ajcn\/67.2.263","article-title":"Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study","volume":"67","author":"Nygard","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.contraception.2005.09.011_bib16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1055\/s-2000-8471","article-title":"Biological and environmental determinants of plasma homocysteine","author":"Scheede","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.contraception.2005.09.011_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0188-4409(01)00379-4","article-title":"Insulin increases homocysteine levels in a dose-dependent manner in diabetic rats","volume":"33","author":"Gursu","year":"2002","journal-title":"Arch Med Res"},{"key":"10.1016\/j.contraception.2005.09.011_bib18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9150(01)00531-7","article-title":"Homocysteine and cardiovascular disease in diabetes mellitus","volume":"159","author":"Audelin","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.contraception.2005.09.011_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0895-7061(99)00138-7","article-title":"Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects","volume":"13","author":"Sheu","year":"2000","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.contraception.2005.09.011_bib20","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0015-0282(01)01937-9","article-title":"Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome","volume":"76","author":"Yarali","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2005.09.011_bib21","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/humrep\/deg190","article-title":"Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine","volume":"18","author":"Schachter","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2005.09.011_bib22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1507\/endocrj.51.601","article-title":"Plasma homocysteine levels in polycystic ovary syndrome and congenital adrenal hyperplasia","volume":"51","author":"Bayraktar","year":"2004","journal-title":"Endocr J"},{"key":"10.1016\/j.contraception.2005.09.011_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1447-0756.2001.tb01241.x","article-title":"Plasma homocysteine, fasting insulin and androgen patterns among women with polycystic ovaries and infertility","volume":"27","author":"Still","year":"2001","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.contraception.2005.09.011_bib24","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0015-0282(98)00469-5","article-title":"Adrenal dynamic responses to physiologic and pharmacologic adrenocorticotropic hormone stimulation before and after ovarian steroid modulation in women with polycystic ovary syndrome","volume":"71","author":"Gonzalez","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2005.09.011_bib25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2337\/diacare.21.2.310","article-title":"Consensus Development Conference on Insulin Resistance; 5\u20136 November 1997","volume":"21","author":"American Diabetes Association","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.contraception.2005.09.011_bib26","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/s-2007-1013559","article-title":"Estimates of in vivo insulin action in humans: comparison of the insulin clamp and the minimal model techniques","volume":"17","author":"Foley","year":"1985","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.contraception.2005.09.011_bib27","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1210\/jc.2003-030328","article-title":"Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel","volume":"88","author":"Cagnacci","year":"2003","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782405003690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782405003690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T06:07:15Z","timestamp":1554530835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782405003690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0010782405003690"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2005.09.011","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}